Home > Information
Information
- May 29, 2023
- Visit by Stella Kyriakides, European commissioner for Health and Food Safety
- May 24, 2023
- G7 Cancer is launched
- Apr. 19, 2023
- World-first confirmation of standard treatment for RAS wild-type colorectal cancer－Paper published in JAMA－
- Apr. 12, 2023
- Start of Clinical Research of the First Japanese-Produced Next-Generation Photon Counting Computed Tomography
- Apr. 10, 2023
- Efficacy of Anti-HER2 Therapy with Trastuzumab Deluxecan in Uterine Carcinosarcoma Consistent with PDX-model predictions of efficacy, paving the way for the development of treatments for rare cancers.
- Apr. 3, 2023
- A clinical trial of Tazemetostat for pediatric and AYA patients with malignant tumors which have no standard treatment or which is refractory to standard treatment using Patient-Proposed Healthcare Service (NCCH2214/ TURTLE trial) to improve drug access for pediatric and AYA patients with refractory tumors.
- Mar. 27, 2023
- President of National Cancer Center Mongolia Visit
- Mar. 14, 2023
- World’s Largest Gastric Cancer Genomic Study Reveals Treatment Targets for Japanese Patients Alcohol intake link gives hope for improving prevention strategies
- Mar. 9, 2023
- President of National Cancer Center Korea Visit
- Mar. 9, 2023
- French National Cancer Institute（INCa）delegation visited
- Mar. 9, 2023
- Franco-Japanese Immuno-Oncology Research Workshop
- Feb. 28, 2023
- Questionable practices identified by an examination of therapeutic plan reviews performed by certified committees under the Act on the Safety of Regenerative Medicine
- Jan. 24, 2023
- Clinical Utility of Circulating Tumor DNA After Surgery for Colorectal Cancer Demonstrated in a Large-Scale Prospective Study －A Step toward Personalized Postoperative Adjuvant Chemotherapy－
- Jan. 5, 2023
- Moonshot Research and Development Program ‘Actualization of a cancer-free society through regulation of chronic inflammation’ launched